Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis

id	oai:revistas.unicordoba.edu.co:article_91
record_format	ojs
spelling	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis Molina D, Víctor Álzate V, David Ruíz B, Jhon Urrea A, Manuela Tobón J, Juan Dog NSAIDS pain pharmacology 19 3 Núm. 3 , Año 2014 : Revista MVZ Córdoba Volumen 19(3) Septiembre-Diciembre 2014 Artículo de revista Journal article 2014-09-20T00:00:00Z 2014-09-20T00:00:00Z 2014-09-20 application/pdf Universidad de Córdoba Revista MVZ Córdoba 0122-0268 1909-0544 https://revistamvz.unicordoba.edu.co/article/view/91 10.21897/rmvz.91 https://doi.org/10.21897/rmvz.91 https://creativecommons.org/licenses/by-nc-sa/4.0/ 4289 4300 Sanderson RO, Beata C, Flipo R-M, Genevois J-P, Macias C, Tacke S, et al. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009;164:418–24. http://dx.doi.org/10.1136/vr.164.14.418 Innes FJ, Cayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010 Feb 20;166(1):226–30. http://dx.doi.org/10.1136/vr.c97 Lizarraga Madrigal I, Sumano Lopez H, Castillo Alcala F. Cyclooxygenase-2 selective inhibitors: Potential usage in dogs. Vet Mex. 2002;33(3):2–24. Johnston S, M.McLaughlin R, Budsberg SC. Nonsurgical Management of Osteoar thritis in Dogs. Vet Clin Small Anim. 2008;38:1449–70. http://dx.doi.org/10.1016/j.cvsm.2008.08.001 Aragon CL, Hofmeister EH, Budsberg S. Systematic review of clinical trials of treatments for osteoarthritis in dogs. JAVMA. 2007;230(4):514–21. http://dx.doi.org/10.2460/javma.230.4.514 Henderson AK, Webster CLR. Disruption of the Gastric Mucosal Barrier in Dogs [Internet]. CompendiumVet.com. 2006. Available from: http://cp.vetlearn.com/Media/PublicationsArticle/PV_28_05_340.pdf Nakagawa K, Yamagami T, Takemura N. Hepatocellular toxicosis associated white the alternate administration of carprofen and meloxicam in a siberian husky. j.vet.med.sci. 2005;67(10):1051–3. Batlouni M. Antiinflamatorios No Esteroides: Efectos Cardiovasculares, Cerebrovasculares y Renales. Arq Bras Cardiol. 2010; 94(4):538-46. Autefage A, Palissier FM, Asimus E, Pepin-Richard C. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis. Vet Rec. 2011;168:617–23. http://dx.doi.org/10.1136/vr.d1456 Bergh MS, Budsberg S. The coxib NSAIDs: potential clinical and phamacologic importance in veterinary medicine. J Vet Intern Med. 2005;19(1):633–43. http://dx.doi.org/10.1111/j.1939-1676.2005.tb02741.x Choitsu SC, Soen S. Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan. Digestion. 2011;83(1):108–23. Anderson A. Treatment of hip dysplasia. J Small Anim Pract. 2011;52:182–9. http://dx.doi.org/10.1111/j.1748-5827.2011.01049.x Michelin A de F, Ferreira Peres AA, Bitar Galvini B, Lopez Cruz L. Toxicidade renal de inhibidores selectivos da cicloxigenasa 2 : celecoxib e rofecoxib. Rev Ciênc Méd Campinas. 2006;4(15):322–32. Vásquez-Cotés S, Vásquez-Fuertes L, Rodríguez-Alvárez M, Reig-Rincón de Arellano I, Martínez-Cócera C. Tolerancia a celecoxib y meloxicam en pacientes con intolerancia a analgésicos no esteroides. Med Interna. 2008;25(4):163–7. Luna S, Bastilio A, Steagall P. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen and meloxicam in dogs. Am J Vet Res. 2007;68:258–64. http://dx.doi.org/10.2460/ajvr.68.3.258 Doig PA, Purbrick KA, Hare JE, McKeown DB. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J. 2000;41(1):296–300. Tabibian J, Tabibian N, Kaufman D. Late-onset celecoxib induced combined hepato nephrotoxicity. Br J Clin Pharmacol. 2008;66(1):150–2. http://dx.doi.org/10.1111/j.1365-2125.2008.03157.x Joubert KE. The effects of firocoxib (previcox) in geriatric dogs over a period of 90 days. JSAfr.vetASS. 2009;60(3):179–84. Roberts ES, Van Lare KA, Marable BR, Salminen WF. Safety and tolerability of 3 week and 6 moths dosing of Deracoxib (Deramaxx) chewable tablets in dogs. Jvet Paharmacol Ther. 2008;32(329):337. Agustí A, Danés I. Modificación del efecto antiagregante de ácido acetil salicílico por los fármacos antiinflamatorios no esteroideos. Med Clin Barc. 2004;123(11):433–4. http://dx.doi.org/10.1016/S0025-7753(04)74542-X Goodman L, Gilman A, Hardman J, Limbird LE. Goodman & Gilman’s The Pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill; 2006. Lanas Arbeloa Á. Avances en patología gastrointestinal relacionada con el tratamiento con antiinfl amatorios no esteroideos y antiagregantes plaquetarios. Gastroenterol Hepatol. 2011;34(1):35–42. http://dx.doi.org/10.1016/S0210-5705(11)70005-X Firth AM, Haldane SL. Development of a scale to evaluate postoperative pain in dogs. JAVMA. 1999;214(5):651–9. Gómez LF, Hernánndez CA, Restrepo-Betancurt LF, Orozco S. Comparación de etomidato, ketamina y propofol como inductores para gastroduodenoscopia en perros. Rev Colomb Cienc Pecu. 2007;20(1):59–66. Oddone AJ, Rodríguez-Jurado PM. Enfermedades Congénictas y Hereditarias de las Razas Caninas y Felinas. Primera. Buenos Aires: Intermedica; 2010. 147 p. Hou Y, Wang Y, Lust G, Zhu L, Zhang Z, Todhunter RJ. Retrospective Analysis for Genetic Improvement of Hip Joints of Cohort Labrador Retrievers in the United States: 1970–2007. PLoS ONE. 2010;5(2):9410. http://dx.doi.org/10.1371/journal.pone.0009410 Che Y-F, Jobanputra P, Barton P, Bryan, S, Harris, G, Taylor, RS, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(1):25–32. Llau JV, De Andrés, J J, Gomar C, Gómez-Luque A, Hidalgo F, Sahagún J, et al. Fármacos que alteran la hemostasia y técnicas regionales anestésicas y analgésicas: recomendaciones de seguridad (foro de consenso). R E V Soc Esp Dolor. 2001;8(1):337–48. Campora C, Freeman KP, Lewis FI, Gibson G, Sacchini F, Sanchez-Vazquez MJ. Determination of haematological reference intervals in healthy adult greyhounds. JSAP. 2011 Jun;52(1):301–9. http://dx.doi.org/10.1111/j.1748-5827.2011.01070.x Steagall, P, Mantovani FB, Ferreira TH, Salcedo E, Mouthi-o FQ, Luna LS. Evaluation of the adverse effects of oral firocoxib in healthy dogs. J Vet Pharmacol Ther. 2007; 30:2218–23. http://dx.doi.org/10.1111/j.1365-2885.2007.00842.x Chopra S, Kishore-Saini R, Nath-Sanyal S. Intestinal toxicity of non-steroideal anti-inflammatory drugs with differential cyclooxigenase inhibition selectivity. Nutr Hosp. 2007;22(5):528–37. https://revistamvz.unicordoba.edu.co/article/download/91/160 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication
institution	UNIVERSIDAD DE CORDOBA
thumbnail	https://nuevo.metarevistas.org/UNIVERSIDADDECORDOBA/logo.png
country_str	Colombia
collection	Revista MVZ Córdoba
title	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
spellingShingle	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis Molina D, Víctor Álzate V, David Ruíz B, Jhon Urrea A, Manuela Tobón J, Juan NSAIDS pain pharmacology
title_short	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
title_full	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
title_fullStr	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
title_full_unstemmed	Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
title_sort	analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
author	Molina D, Víctor Álzate V, David Ruíz B, Jhon Urrea A, Manuela Tobón J, Juan
author_facet	Molina D, Víctor Álzate V, David Ruíz B, Jhon Urrea A, Manuela Tobón J, Juan
topic	NSAIDS pain pharmacology
topic_facet	NSAIDS pain pharmacology
citationvolume	19
citationissue	3
citationedition	Núm. 3 , Año 2014 : Revista MVZ Córdoba Volumen 19(3) Septiembre-Diciembre 2014
publisher	Universidad de Córdoba
ispartofjournal	Revista MVZ Córdoba
source	https://revistamvz.unicordoba.edu.co/article/view/91
language
format	Article
rights	https://creativecommons.org/licenses/by-nc-sa/4.0/ info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2014-09-20
date_accessioned	2014-09-20T00:00:00Z
date_available	2014-09-20T00:00:00Z
url	https://revistamvz.unicordoba.edu.co/article/view/91
url_doi	https://doi.org/10.21897/rmvz.91
issn	0122-0268
eissn	1909-0544
doi	10.21897/rmvz.91
citationstartpage	4289
citationendpage	4300
url2_str_mv	https://revistamvz.unicordoba.edu.co/article/download/91/160
_version_	1811201065233678336

Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
.